Ulobetasol lotion - Sun Pharmaceutical Industries

Drug Profile

Ulobetasol lotion - Sun Pharmaceutical Industries

Alternative Names: Halobetasol propionate lotion- Sun Pharmaceutical Industries; HBP lotion- Sun Pharmaceutical Industries; Ultravate

Latest Information Update: 28 Apr 2016

Price : $50

At a glance

  • Originator Sun Pharmaceutical Industries
  • Class Anti-inflammatories; Antiallergics; Corticosteroids; Small molecules
  • Mechanism of Action Phospholipase A2 inhibitors; Steroid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Registered Plaque psoriasis

Most Recent Events

  • 28 Apr 2016 Chemical structure information added
  • 18 Apr 2016 Halobetasol propionate lotion has patent protection in USA
  • 04 Mar 2016 Efficacy and adverse events data from two phase III trials in Plaque psoriasis presented at the 74th Annual Meeting of the American Academy of Dermatology (AAD-2016)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top